Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2203-2210

  Wunder, Dorothea M ^a   Guibourdenche, Jean ^b   Birkhäuser, Martin H ^a   Bersinger, Nick A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Anti M llerian hormone; inhibin B; IVF ICSI; reproductive outcome

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; STEROID HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; EMBRYO IMPLANTATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, HUMAN; FOLLICULAR FLUID; HUMANS; INFERTILITY; INHIBINS; LONGITUDINAL STUDIES; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; PROGESTERONE; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 45449093144     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.078     Document Type: Article

References (51)

1. Vigier B., Picard J.Y., Tran D., Legeai L., and Josso N. Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114 (1984) 1315-1320
2. Rey R., Lukas C., Lasala C., and Bedecarras P. AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 211 (2003) 21-31
3. Di Clemente N., Ghaffari S., Pepinsky R., Pican C., Josso N., Cate R.L., et al. A quantitative and interspecific test for biological activity of anti-Mullerian hormone: the fetal ovary aromatase assay. Development 114 (1992) 721-727
4. Weenen C., Laven J.S., Von Bergh A.R., Cranfield M., Groome N.P., Visser J.A., et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10 (2004) 77-83
5. Durlinger A.L., Gruijters M.J., Kramer P., Karels B., Ingraham H.A., Nachtigal M.W., et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143 (2002) 1076-1084
6. Guibourdenche J., Lucidarme N., Chevenne D., Rigal O., Nicolas M., Luton D., et al. Anti-Mullerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol 211 (2003) 55-63
7. Rajpert E., Jorgensen N., Graem N., Muller J., Cate R.L., and Skakkebaek N.E. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84 (1999) 3836-3844
8. La Marca A., De Leo V., Giulini S., Orvieto R., Malmusi S., Gianella L., et al. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Invest 12 (2005) 545-548
9. Te Velde E.R., and Pearson P.L. The variability of female reproductive ageing. Hum Reprod Update 8 (2002) 141-154
10. Themmen A.P. Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr 34 (2005) 18-21
11. Rey R., Sabourin J.C., Venara M., Long W.Q., Jaubert F., Zeller W.P., et al. Anti-Mullerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumours. Hum Pathol 31 (2000) 1202-1208
12. La Marca A., and Volpe A. The anti-mullerian hormone and ovarian cancer. Hum Reprod Update 13 (2007) 265-273
13. Eldar-Geva T., Margalioth E.J., Gal M., Ben-Chetrit A., Algur N., Zylber-Haran E., et al. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 20 (2005) 1814-1819
14. Penarrubia J., Fabregues F., Manau D., Creus M., Casals G., Casamitjana R., et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod 20 (2005) 915-922
15. De Vet A., Laven J.S., de Jong F.H., Themmen A.P., and Fauser B.C. Anti-Mulllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77 (2002) 357-362
16. Fanchin R., Schonauer L.M., Righini C., Guibourdenche J., Frydman N., Frydman R., et al. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18 (2003) 323-327
17. Fanchin R., Taieb J., Méndez D.H., Ducot B., Frydman R., and Bouyer J. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20 (2005) 923-927
18. Muttukrishna S., McGarrigle H., Wakim R., Khadum I., Ranieri D.M., and Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. Brit J Obstet Gynaecol 112 (2005) 1384-1390
19. Tremellen K.P., Kolo M., Gilmore A., and Lekamge D.N. Anti-Mullerian hormone as a marker of ovarian reserve. Aust NZ J Obstet Gynaecol 45 (2005) 20-24
20. Hazout A. Qualité de la réserve folliculaire ovarienne: inhibine B au troisième jour du cycle ou hormone antimullérienne (AMH)?. Gynecol Obstet Fertil 34 (2006) 1001-1002
21. Piltonen T., Morin-Papunen L., Koivunen R., Perheentupa A., Ruokonen A., and Tapanainen J.S. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20 (2005) 1820-1826
22. Fleming R., Deshpande N., Traynor I., and Yates R.W. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone. Hum Reprod 21 (2006) 1436-1441
23. Smeenk J.M., Sweep F.C., Zielhuis G.A., Kremer J.A., Thomas C.M., and Braat D.D. Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 87 (2007) 223-226
24. Van Rooij I.A., Broekmans F.J., Te Velde E.R., Fauser B.C., Bancsi L.F., De Jong F.H., et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17 (2002) 3065-3071
25. Ebner T., Sommergruber M., Moser M., Shebl O., Schreier E., and Tews G. Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 21 (2006) 2022-2026
26. Ficicioglu C., Kutlu T., Baglam E., and Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 85 (2006) 592-596
27. Fréour T., Mirallié S., Colombel A., Bach-Ngohou K., Masson D., and Barrière P. Anti-mullerian hormone: clinical relevance in assisted reproductive therapy. Ann Endocrinol 67 (2006) 567-574
28. Hazout A., Bouchard P., Seifer D.B., Aussage P., Junca A.M., and Cohen-Bacrie P. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 82 (2004) 1323-1329
29. Fanchin R., Mendez D.H., Louafi N., Achour N., Frydman R., and Taieb J. Dynamics of serum anti-Mullerian hormone levels during the luteal phase of controlled ovarian hyperstimulation. Hum Reprod 20 (2005) 747-751
30. La Marca A., and Volpe A. Anti-mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?. Clin Endocrinol 64 (2006) 603-610
31. Wunder D.M., Bersinger N.A., Yared M., Kretschmer R., and Birkhauser M.H. Statistically significant changes of antimullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril (2007 June 29) [E-pub ahead of print]
32. Laven J.S., Mulders A.G., Visser J.A., Themmen A.P., De Jong F.H., and Fauser B.C. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89 (2004) 318-323
33. Lekamge D.N., Barry M., Kolo M., Lane M., Gilchrist R.B., and Tremellen K.P. Anti-Mullerian hormone as a predictor for IVF outcome. Reprod Biomed Online 14 (2007) 602-610
34. Eldar-Geva T., Ben-Chetrit A., Spitz I.M., Rabinowitz R., Markowitz E., Mimoni T., et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 20 (2005) 3178-3183
35. Silberstein T., MacLaughlin D.T., Shai I., Trimarchi J.R., Lambert G., Seifer D.B., et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod 21 (2006) 159-163
36. Fanchin R., Louafi N., Mendez D.H., Frydman N., Frydman R., and Taieb J. Per-follicle measurements indicate that anti-Mullerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril 84 (2005) 167-173
37. Takahashi C., Fujito A., Kazuka M., Sugiyama R., Ito H., and Isaka K. Antimullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril (2007 Jun 1) [E-pub ahead of print]
38. Wunder D.M., Kretschmer R., and Bersinger N.A. Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles. Hum Reprod 20 (2005) 1266-1271
39. Gregory L., Booth A.D., Wells C., and Walker S.M. A study of the cumulus-corona cell complex in in-vitro fertilization and embryo transfer; a prognostic indicator of the failure of implantation. Hum Reprod 9 (1994) 1308-1317
40. Tesarik J., and Sousa M. Key elements of highly efficient intracytoplasmic sperm injection technique: Ca+ fluxes and oocyte cytoplasmic dislocation. Fertil Steril 64 (1995) 770-776
41. Scott L., Alvero R., Leondires M., and Miller B. The morphology of human pronuclear embryos is positively related to blastocyst development and implantation. Hum Reprod 15 (2000) 2394-2403
42. Visser D.S., and Fourie F le R. The applicability of the cumulative embryo score system for embryo selection and quality control in an in-vitro fertilization/embryo transfer programme. Hum Reprod 8 (1993) 1719-1722
43. Terriou P., Sapin C., Giorgetti C., Hans E., Spach J.L., and Roulier R. Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertil Steril 75 (2001) 525-531
44. Carlberg M., Nejaty J., Fröysa B., Guan Y., Söder O., and Berqvist A. Elevated expression of tumour necrosis factor α in cultured granulosa cells from women with endometriosis. Hum Reprod 15 (2000) 1250-1255
45. Lédée-Bataille N., Laprée-Delage G., Taupin J.L., Dubanchet S., Taieb J., Moreau J.F., et al. Follicular fluid concentration of leukemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles. Hum Reprod 16 (2001) 2073-2078
46. Wunder D.M., Kretschmer R., and Bersinger N.A. Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles. Hum Reprod 20 (2005) 1266-1271
47. Wunder D.M., Mueller M.D., Birkhauser M.H., and Bersinger N.A. Increased ENA-78 in the follicular fluid of patients with endometriosis. Acta Obstet Gynecol Scand 85 (2006) 336-342
48. Long W.Q., Ranchin V., Pautier P., Belville C., Denizot P., Cailla H., et al. Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumour by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 85 (2000) 540-544
49. Elgindy E.A., El-Haieg D.O., and El-Sebaey A.E. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril (2007 July 19) [E-pub ahead of print]
50. Fréour T., Mirallié S., Bach-Ngohou K., Denis M., Barrière P., and Masson D. Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology. Clin Chim Acta 375 (2007) 162-164
51. Bersinger N.A., Wunder D., Birkhäuser M.H., and Guibourdenche J. Measurement of anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid. Clin Chim Acta 384 (2007) 174-175